Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis

[1] Cao GW(2009)Clinical relevance and public health significance of hepatitis B virus genomic variations World J Gastroenterol 15 5761-5769

[2] Ganem D(2004)Hepatitis B virus infection--natural history and clinical consequences N Engl J Med 350 1118-1129

[3] Prince AM(2006)Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 65-73

[4] Chen CJ(2006)Predicting cirrhosis risk based on the level of circulating hepatitis B viral load Gastroenterology 130 678-686

[5] Yang HI(2008)Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach Gastroenterology 134 405-415

[6] Su J(2011)Long-Term Nucleos(t)ide Analogues Therapy for Adults With Chronic Hepatitis B reduces the Risk of Long-Term Complications: a meta-analysis Virol J 8 72-271

[7] Jen CL(2009)Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis J Viral Hepat 16 265-696

[8] You SL(2003)Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B Clin Infect Dis 36 687-539

[9] Lu SN(2007)Chronic hepatitis B Hepatology 45 507-1751

[10] Huang GT(2006)Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years Gastroenterology 131 1743-758

[1] Cao GW(2009)Clinical relevance and public health significance of hepatitis B virus genomic variations World J Gastroenterol 15 5761-5769

[2] Ganem D(2004)Hepatitis B virus infection--natural history and clinical consequences N Engl J Med 350 1118-1129

[3] Prince AM(2006)Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 65-73

[4] Chen CJ(2006)Predicting cirrhosis risk based on the level of circulating hepatitis B viral load Gastroenterology 130 678-686

[5] Yang HI(2008)Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach Gastroenterology 134 405-415

[6] Su J(2011)Long-Term Nucleos(t)ide Analogues Therapy for Adults With Chronic Hepatitis B reduces the Risk of Long-Term Complications: a meta-analysis Virol J 8 72-271

[7] Jen CL(2009)Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis J Viral Hepat 16 265-696

[8] You SL(2003)Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B Clin Infect Dis 36 687-539

[9] Lu SN(2007)Chronic hepatitis B Hepatology 45 507-1751

[10] Huang GT(2006)Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years Gastroenterology 131 1743-758